Resonance Health Limited (ASX:RHT) Insider Acquires A$17,500.00 in Stock

Resonance Health Limited (ASX:RHT) insider Simon Panton acquired 500,000 shares of the business’s stock in a transaction dated Monday, June 23rd. The stock was purchased at an average price of A$0.04 ($0.02) per share, with a total value of A$17,500.00 ($11,513.16).

Resonance Health Stock Performance

The firm has a market cap of $28.50 million, a price-to-earnings ratio of 168.79 and a beta of 1.32. The company has a quick ratio of 9.76, a current ratio of 1.51 and a debt-to-equity ratio of 33.81.

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report.